Skip to main content

Table 2 Performance of the considered classifiers and the Mayo Scoring system

From: Combining epigenetic and clinicopathological variables improves specificity in prognostic prediction in clear cell renal cell carcinoma

 

Classifier

Sensitivity (%)

Specificity (%)

A

Mayo scoring system (Mayo)

85

50

B

Clinicopathological variables (Clinical)

85

43

C

Identified prognostic biomarker CpGs (PI-CpGs)

85

59

D

Consensus variables (DCA)

85

43

E

Clinical + PI-CpGs

85

55

F

Clinical + DCA

85

53

G

Clinical + PI-CpGs + DCA (the triple classifier)

85

64